Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.6816 Delayed Data As of 3:59pm ET |  +0.0331 / +5.10%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +33.91% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 39.5M | 32.3M | 52.0M | 76.9M | |
| Short Term Investment Cash | 24.6M | -7.2M | 19.7M | 24.9M | ||
| Cash & Short Term Investments | 74.5M | 103.1M | 108.1M | 76.9M | ||
| Receivables | Receivables | 32.0K | -- | -- | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 282.0K | 426.0K | 740.0K | 237.0K | |
| Current Assets | 74.8M | 103.5M | 108.8M | 77.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | 179.0K | 1.0M | 1.4M | 843.0K | |
| Depreciation | -90.0K | -175.0K | -535.0K | -443.0K | ||
| Other Assets | 0.00 | 0.00 | 599.0K | 53.0K | ||
| Total Assets | 113.3M | 154.4M | 110.3M | 77.6M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 0.00 | 702.0K | |
| Accrued Expenses | -- | 1.6M | 2.7M | 3.9M | ||
| Other Current Liabilities | 2.3M | 8.5M | 9.4M | 3.9M | ||
| Other Liabilities | 4.8M | 9.5M | 11.0M | 4.6M | ||
| Total Liabilities | Long Term Debt | 131.0K | 47.0K | 33.0K | 6.0K | |
| Total Liabilities | 4.9M | 9.7M | 11.4M | 4.9M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 108.4M | 144.7M | 98.9M | 72.7M | ||
| Total Shareholder Equity | 108.4M | 144.7M | 98.9M | 72.7M | ||
| Share Information | Common Shares Outstanding | 17.2M | 23.4M | 23.5M | 23.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
